Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction

A new scoring system Outcomes Registry for Better Informed Treatment (ORBIT) score is used to assess the bleeding risk in anticoagulated patients with atrial fibrillation (AF). Our aim is to investigate the possible correlations of the ORBIT score with 30-day mortality in patients with ST-segment el...

Full description

Bibliographic Details
Main Authors: Jun-Hua Shen MD, Hui-Min Wang MD, Kou-Long Zheng MD, Hui-He Lu MD, Qing Zhang PhD
Format: Article
Language:English
Published: SAGE Publishing 2020-09-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029620940047
_version_ 1819090870729703424
author Jun-Hua Shen MD
Hui-Min Wang MD
Kou-Long Zheng MD
Hui-He Lu MD
Qing Zhang PhD
author_facet Jun-Hua Shen MD
Hui-Min Wang MD
Kou-Long Zheng MD
Hui-He Lu MD
Qing Zhang PhD
author_sort Jun-Hua Shen MD
collection DOAJ
description A new scoring system Outcomes Registry for Better Informed Treatment (ORBIT) score is used to assess the bleeding risk in anticoagulated patients with atrial fibrillation (AF). Our aim is to investigate the possible correlations of the ORBIT score with 30-day mortality in patients with ST-segment elevation myocardial infarction (STEMI). A total of 639 patients with STEMI were enrolled in this study. The ORBIT, HAS-BLED, and TIMI scores were recorded during admission. After 30 days’ follow-up, 639 patients were divided into 2 groups: the survival group and the nonsurvival group. Different clinical parameters were compared. The predictive values of the ORBIT, HAS-BLED, and TIMI scores for 30-day mortality were assessed from receiver operating characteristic (ROC) analyses. The univariate and multivariate Cox proportional hazards analyses were applied to evaluate the relationships between variables and 30-day mortality. Sixty-seven deaths occurred after a 30-day follow-up. The ORBIT, HAS-BLED, and TIMI scores in the death group were higher than those in the survival group ( P < .05). The areas under the ROC curve for the ORBIT, HAS-BLED, and TIMI scores to predict the occurrence of 30-day mortality were 0.811 (95% CI: 0.779-0.841, P < .0001), 0.717 (95% CI: 0.680-0.752, P < .0001), and 0.844 (95% CI: 0.813-0.871, P < .0001), respectively. In multivariate Cox proportional hazards modeling, the high ORBIT score was positively associated with 30-day mortality (hazard ratio: 1.309, 95% CI: 1.101-1.556, P = .013) after adjustment. A graded relation is found in the elevated ORBIT score and 30-day mortality in patients with STEMI. Thus, the ORBIT score can be an independent predictor of 30-day mortality in patients with STEMI.
first_indexed 2024-12-21T22:30:42Z
format Article
id doaj.art-c149f56561da48c184a5c05535089428
institution Directory Open Access Journal
issn 1938-2723
language English
last_indexed 2024-12-21T22:30:42Z
publishDate 2020-09-01
publisher SAGE Publishing
record_format Article
series Clinical and Applied Thrombosis/Hemostasis
spelling doaj.art-c149f56561da48c184a5c055350894282022-12-21T18:48:06ZengSAGE PublishingClinical and Applied Thrombosis/Hemostasis1938-27232020-09-012610.1177/1076029620940047Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial InfarctionJun-Hua Shen MD0Hui-Min Wang MD1Kou-Long Zheng MD2Hui-He Lu MD3Qing Zhang PhD4 Emergency Department, The Second Affiliated Hospital of Nantong University, China Department of Cardiology, The Second Affiliated Hospital of Nantong University, China Department of Cardiology, The Second Affiliated Hospital of Nantong University, China Department of Cardiology, The Second Affiliated Hospital of Nantong University, China Department of Cardiology, The Second Affiliated Hospital of Nantong University, ChinaA new scoring system Outcomes Registry for Better Informed Treatment (ORBIT) score is used to assess the bleeding risk in anticoagulated patients with atrial fibrillation (AF). Our aim is to investigate the possible correlations of the ORBIT score with 30-day mortality in patients with ST-segment elevation myocardial infarction (STEMI). A total of 639 patients with STEMI were enrolled in this study. The ORBIT, HAS-BLED, and TIMI scores were recorded during admission. After 30 days’ follow-up, 639 patients were divided into 2 groups: the survival group and the nonsurvival group. Different clinical parameters were compared. The predictive values of the ORBIT, HAS-BLED, and TIMI scores for 30-day mortality were assessed from receiver operating characteristic (ROC) analyses. The univariate and multivariate Cox proportional hazards analyses were applied to evaluate the relationships between variables and 30-day mortality. Sixty-seven deaths occurred after a 30-day follow-up. The ORBIT, HAS-BLED, and TIMI scores in the death group were higher than those in the survival group ( P < .05). The areas under the ROC curve for the ORBIT, HAS-BLED, and TIMI scores to predict the occurrence of 30-day mortality were 0.811 (95% CI: 0.779-0.841, P < .0001), 0.717 (95% CI: 0.680-0.752, P < .0001), and 0.844 (95% CI: 0.813-0.871, P < .0001), respectively. In multivariate Cox proportional hazards modeling, the high ORBIT score was positively associated with 30-day mortality (hazard ratio: 1.309, 95% CI: 1.101-1.556, P = .013) after adjustment. A graded relation is found in the elevated ORBIT score and 30-day mortality in patients with STEMI. Thus, the ORBIT score can be an independent predictor of 30-day mortality in patients with STEMI.https://doi.org/10.1177/1076029620940047
spellingShingle Jun-Hua Shen MD
Hui-Min Wang MD
Kou-Long Zheng MD
Hui-He Lu MD
Qing Zhang PhD
Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
Clinical and Applied Thrombosis/Hemostasis
title Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
title_full Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
title_fullStr Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
title_full_unstemmed Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
title_short Correlation of the ORBIT Score With 30-Day Mortality in Patients With ST-Segment Elevation Myocardial Infarction
title_sort correlation of the orbit score with 30 day mortality in patients with st segment elevation myocardial infarction
url https://doi.org/10.1177/1076029620940047
work_keys_str_mv AT junhuashenmd correlationoftheorbitscorewith30daymortalityinpatientswithstsegmentelevationmyocardialinfarction
AT huiminwangmd correlationoftheorbitscorewith30daymortalityinpatientswithstsegmentelevationmyocardialinfarction
AT koulongzhengmd correlationoftheorbitscorewith30daymortalityinpatientswithstsegmentelevationmyocardialinfarction
AT huihelumd correlationoftheorbitscorewith30daymortalityinpatientswithstsegmentelevationmyocardialinfarction
AT qingzhangphd correlationoftheorbitscorewith30daymortalityinpatientswithstsegmentelevationmyocardialinfarction